Europe changes its tune on Covid-19 vaccine IP, advocating now for a 'targeted waiver'
Just a month after it seemed like negotiations were getting nowhere fast on waiving the intellectual property around Covid-19 vaccines ahead of a December deadline, the European Commission has now gone from threatening to veto any IP waiver to calling for a waiver.
The push for an IP waiver at the WTO is part of efforts to get more shots in the arms of people in low- and middle-income countries. Less than 1% of doses worldwide have been administered in low-income countries so far.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 124,600+ biopharma pros reading Endpoints daily — and it's free.